Lanean...
Recent advances in the HER2 targeted therapy of gastric cancer
Recent advances in molecular targeted therapies, including targeting human epidermal growth factor receptor 2 (HER2), had a major forward step in the therapy for gastric cancer patients. Application of HER2-targeted therapies, in particular trastuzumab in combination with chemotherapy in metastatic...
Gorde:
| Argitaratua izan da: | World J Clin Cases |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Baishideng Publishing Group Inc
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4295218/ https://ncbi.nlm.nih.gov/pubmed/25610849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v3.i1.42 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|